国际标准期刊号: ISSN 2472-016X

骨科肿瘤学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Does Health Disparity Exist in the Management of Benign Bone Tumors?

Andrew Muran MPhil, John Fallon, Matthew Rohde, Jonathan Sgaglione, Byeongho Jung, Peter Dzaugis, Aaron Zhang, Michael Fitzgerald, Howard Goodman J, Samuel Kenan, Shachar Kenan

Background: Healthcare disparity in the United States has been a concern in multiple fields of medicine, resulting in unequal distribution of resources among different populations based on race, location, and socioeconomic status. Healthcare providers seek to offer equal care to all, but access to care may be limited by multiple factors. Whether this applies to the management of benign bone lesions is unknown. The objective of this study was to assess how race and socioeconomic factors may affect patient treatment in the setting of benign bone lesions.

Methods: This multicenter retrospective observational study investigated the relationship between socioeconomic status and race with diagnosis (lesion type) and treatment (operative vs. non-operative), using a large database of benign bone lesion patients collected from suburban New York (N = 689). Patients of all ages diagnosed with a benign bone lesion between 2007 and 2021 were included in this study and 2021 US Census Bureau data for each patient’s zip code was used as a proxy for socioeconomic and racial status. Multivariate analyses of variance and cross tabulations were performed with bootstrapping to examine differences regarding tumor diagnosis and surgical intervention by racial/ethnic and socioeconomic variables.

Results: There were no statistically significant differences at the .05 level of probability (applying two-tailed tests) for diagnosis and intervention by these variables.

Conclusion: Diagnosis and intervention were not affected by various racial/ethnic and socioeconomic factors in this suburban New York cohort. In benign bone lesion treatment, healthcare disparities may be less prevalent than previously anticipated.